Selected Talks

HDCN Nursing Channel CEU Lecture Series
You need a PAID SUBSCRIPTION TO HDCN before you can access this material. A GREY CE Post-Test Link means that the continuing education credit feature is not yet ready for use.

Vascular Access: The Catheter Conundrum
Lesley C. Dinwiddie, RN, CNN, MSN, FNP

Dialysis Patient Education
Susan K. Hansen, RN, CNN, CHT

The Non-Compliant Patient
Susan K. Hansen, RN, CNN, CHT
(More to come!)

See each individual talk link for educational objectives.
Lesley C. Dinwiddie, RN, CNN, MSN, FNP
Lesley Dinwiddie is a Clinical Instructor with the Division of Nephrology at the University of North Carolina. Ms Dinwiddie's nephrology nursing career began in 1980 as a staff nurse and led to a transplant coordinator role with subsequent positions in hemodialysis patient care. Her current position incorporates research and teaching but the emphasis is on vascular access coordination and care for the UNC hemodialysis outpatients. Ms Dinwiddie serves on a CMS committee that oversees the Clinical Performance Measures instituted to track efficacy of the KDOQI Guidelines as well as being an Editorial Board Member for the Nephrology Nursing Journal.

Susan K. Hansen, RN, CNN, CHT
Susan Hansen has been active in nephrology for 35 years. She has held positions in clinical and laboratory research, staff educations, home hemodialysis training, an academic faculty appointment, was Executive Editor of the Journal Dialysis and Transplantation, and has worked as marketing manager for two major dialysis product corporations. She is currently the Executive Director of the Renal Education Association.

Each talk, depending on its length, is accredited for up to 1.0 CEU credit hours by the Renal Education Association. .
Date of Original Release: See individual talks
CEU Credit Eligible Through: See individual talks
CEU Credit Hours/Completion Time: See individual talks
Target Audiences: Nephrology Nurses and Technicians.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures will allow nephrology nurses, pharmacists, and technicians to obtain up-to-date information about issues related to care of renal patients.

The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (Provider number: CEP 13092).

The Renal Education Association designates this educational activity for continuing education credits (CEUs) for nurses.

The Renal Education Association, as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Ms. Hansen: No financial relationships with commercial entities related to this presentation

Ms. Dinwiddie: No financial relationships with commercial entities related to this presentation

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The Renal Education Association, and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.